Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. NOVO
  4. NOVO — Februar 2026

NOVO — Februar 2026

Planlagt Fastgjort Låst Flyttet NOVO
875 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • CupcakeC Offline
    CupcakeC Offline
    Cupcake
    wrote on sidst redigeret af
    #388

    Marketwire/Medwatch “Børshuset Zacks sakser både anbefaling og kursmål for Novo
    Zacks har sænket anbefalingen til Novo Nordisks amerikanske notering.” $ 65 til 43

    1 Reply Last reply
    0
    • CupcakeC Offline
      CupcakeC Offline
      Cupcake
      wrote on sidst redigeret af
      #389

      (fort.) “Neutral til underperform”

      1 Reply Last reply
      0
      • P Offline
        P Offline
        pauly
        wrote on sidst redigeret af
        #390

        Så tror Zacks i alt fald ikke på FDA slår ned på compounding

        1 Reply Last reply
        0
        • P Offline
          P Offline
          ProinvestorNEWS
          wrote on sidst redigeret af
          #391

          Onsdagens nyheder fra danske medier med EU, Novo og Lån & Spar Bank https://proinvestor.com/investornyt/1413322/onsdagens-nyheder-fra-danske-medier-med-eu-novo-og-lan-spar-bank

          1 Reply Last reply
          0
          • CupcakeC Offline
            CupcakeC Offline
            Cupcake
            wrote on sidst redigeret af
            #392

            Børsen Podcast her til middag
            "Novo og FDA tager opgør med kopier: Hvad sker der så nu?" https://podcasts.apple.com/dk/podcast/børsen-investor/id1626256471

            1 Reply Last reply
            0
            • P Offline
              P Offline
              pauly
              wrote on sidst redigeret af
              #393

              Novo på Bloomberg https://www.youtube.com/watch?v=v89hi_E3zWo

              1 Reply Last reply
              0
              • AlbertoA Offline
                AlbertoA Offline
                Alberto
                wrote on sidst redigeret af
                #394

                Boomberg var god - Børsen det rene ingenting!! Mærkeligt at de helliger en potcast til at fremhæve selvfølgeligheder, som om lytterne ikke vidste noget som helst om industrien, firmaet mv. - Bloomberg var god, fordi den er US made og på den måde giver et billede af tankegangene derovre.. Ingen nævnte for alvor fedmeprodukternes overgang fra blockbuster (med høj pris) til nødvendig strukturel infrastruktur (med høj volumen)...

                1 Reply Last reply
                0
                • AlbertoA Offline
                  AlbertoA Offline
                  Alberto
                  wrote on sidst redigeret af
                  #395

                  ... Vi skal nok 1/2 år frem for at høre om Novo`s ret markante muligheder i det marked med ekstrem masseproduktion, der venter forude... Gos dag til alle

                  1 Reply Last reply
                  0
                  • P Offline
                    P Offline
                    ProinvestorNEWS
                    wrote on sidst redigeret af
                    #396

                    Hansen og Larsen analyserer ugens dramatiske fald i blandt andet sølv og Bitcoin samt de seneste C25-regnskaber fra selskaber som Novo Nordisk og Vestas. Få overblikket over FDA's indgriben mod Him's & Her's fedmepille, og hvad det kan få af betydning for Novo Nordisk. De ser også nærmere på de næste træk i kampen mod Eli Lilly og fremtiden for vægttabsmarkedet. https://proinvestor.com/boards/131102

                    1 Reply Last reply
                    0
                    • P Offline
                      P Offline
                      ProinvestorNEWS
                      wrote on sidst redigeret af
                      #397

                      ResearchPulse
                      @ResearchPulse1
                      Week 5 wegovy pill sales revealed. 246,000 in total for first 5 weeks!

                      $NVI CEO Mike D just said in interview at Fox Business that after 5 weeks total Wegovy pill TRx is 246,000!

                      This would imply week 5 TRx at about 76,000! https://www.foxbusiness.com/video/6389074266112

                      1 Reply Last reply
                      0
                      • CupcakeC Offline
                        CupcakeC Offline
                        Cupcake
                        wrote on sidst redigeret af
                        #398

                        Mike D gør en god figur i interviewet på FOX News, jf. 11/2 17:37. Fin reklame og lutter soft balls gennem hele 20 minutter. Man skulle tro Bartiromo havde en andel i TrumpRx.gov.

                        1 Reply Last reply
                        0
                        • P Offline
                          P Offline
                          ProinvestorNEWS
                          wrote on sidst redigeret af
                          #399

                          Investseekers
                          @investseekers
                          More than a third of patients starting Novo Nordisk’s $NVO Wegovy pill are new to GLP-1s, according to health data firm Truveta.

                          Among 8,762 early users:

                          • 36% had no prior GLP-1 experience

                          • 21.1% switched from injectable Wegovy

                          • 15.8% switched from Lilly’s $LLY Zepbound

                          Early data suggests the oral launch is expanding the market, not just cannibalizing injections. https://www.reuters.com/business/healthcare-pharmaceuticals/more-than-third-patients-wegovy-pill

                          1 Reply Last reply
                          0
                          • J Offline
                            J Offline
                            JKY_VH
                            wrote on sidst redigeret af
                            #400

                            Tak PN, det ser godt ud:-)

                            1 Reply Last reply
                            0
                            • P Offline
                              P Offline
                              pauly
                              wrote on sidst redigeret af
                              #401

                              Han gør det godt på TV ham Mike synes jeg

                              1 Reply Last reply
                              0
                              • CupcakeC Offline
                                CupcakeC Offline
                                Cupcake
                                wrote on sidst redigeret af
                                #402

                                Børsen 20:16 "Studie: Novo kaprer kunder fra hovedri­valen med Wegovy-pillen" + Næsten 16% af de patienter, der har fået en recept på Novo nye vægttabspille, var før brugere af konkurrenten Eli Lillys Zepbound." https://borsen.dk/nyheder/virksomheder/studie-novo-kaprer-kunder-fra-hovedrivalen-med-wegovy-pillen?

                                1 Reply Last reply
                                0
                                • Helge_LarsenPI-redaktørH Offline
                                  Helge_LarsenPI-redaktørH Offline
                                  Helge_LarsenPI-redaktør
                                  wrote on sidst redigeret af
                                  #403

                                  HIMS er presset fra flere sider https://proinvestor.com/boards/131108

                                  1 Reply Last reply
                                  0
                                  • StockBullS Offline
                                    StockBullS Offline
                                    StockBull
                                    wrote on sidst redigeret af
                                    #404

                                    Selv om det ser lovende ud med Novo Nordisk's nye orale GLP-1-pille er jeg stadig ikke sikker på, at fremtiden bliver nogen guldgrube for Novo og sektoren som helhed. Jeg har lavet dette lille skriv netop for at forklare hvorfor – og det handler om skiftet fra hype-drevet til moat-drevet industri: https://proinvestor.com/boards/131076/$/131109

                                    1 Reply Last reply
                                    0
                                    • I Offline
                                      I Offline
                                      Insolvens
                                      wrote on sidst redigeret af
                                      #405

                                      Når jeg læser dit skriv, så bliver jeg lidt i tvivl om, hvorvidt du ser eller ikke ser patenter som en moat ?

                                      1 Reply Last reply
                                      0
                                      • CupcakeC Offline
                                        CupcakeC Offline
                                        Cupcake
                                        wrote on sidst redigeret af
                                        #406

                                        Næsespray Reuters "Chinese biotech aims to finish trials by 2028 for spray with Wegovy active ingredient" https://www.reuters.com/business/healthcare-pharmaceuticals/china-biotech-aims-finish-trials-by-2028-spray-with-wegovy-active-ingredient-2026-02-10/

                                        1 Reply Last reply
                                        0
                                        • P Offline
                                          P Offline
                                          ProinvestorNEWS
                                          wrote on sidst redigeret af
                                          #407

                                          ResearchPulse
                                          @ResearchPulse1
                                          ·
                                          37 min
                                          It has long been rumoured that $NVO would launch wegovy in vials in US. If that happens it will be priced lower than current cash pay prices for wegovy.

                                          Those prices are currently $199 for your two first low doses. Thereafter $345 for the rest.

                                          Novo also expects to launch wegovy in their multi dose FlexTouch pen later this year

                                          FlexTouch is the same pen Ozempic is sold with in US. And same pen all other countries than US have for wegovy.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper